We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3088:TSEMatsukiyoCocokara & Co. Analysis

Data as of 2026-03-11 - not real-time

NT$82.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At a market price of TWD 82, Axiomtek trades well below its DCF‑derived fair value of TWD 121, implying roughly a 14‑15% upside. Its trailing P/E of 18.3 is far under the industry average of 37.2, reinforcing the undervaluation theme. The company delivers a high dividend yield of 5.39% with a payout ratio near 97%, supported by solid operating cash flow (≈ TWD 0.5 bn) and a strong free‑cash‑flow buffer. Balance‑sheet metrics are sound: cash of TWD 1.74 bn dwarfs debt of TWD 0.17 bn, and the debt‑to‑equity ratio is modest.
On the technical side, the 20‑day and 50‑day SMAs sit just below the current price, while the MACD histogram remains negative, signalling short‑term bearish momentum. RSI is neutral at 52, and the stock hovers between its support at TWD 75.8 and resistance at TWD 84, suggesting limited upside in the near term. Volatility is elevated at 34% over 30 days and beta around 0.7, pointing to moderate market sensitivity. The “Extreme Greed” sentiment index (77.2) indicates strong investor appetite, but the recent lack of news adds uncertainty. Given its exposure to AIoT and industrial automation, the company stands to benefit from secular demand trends. However, the high payout ratio leaves limited room for dividend growth should cash generation falter.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Price near resistance at TWD 84
  • Strong dividend yield but high payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF undervaluation with ~14% upside
  • Attractive dividend yield
  • Low beta and solid balance sheet

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular AIoT and industrial automation tailwinds
  • Sustainable cash generation
  • Undervalued relative to industry multiples

Key Metrics & Analysis

Financial Health

Revenue Growth3.40%
Profit Margin7.14%
P/E Ratio18.3
ROE10.26%
ROA5.98%
Debt/Equity3.21
P/B Ratio1.7
Op. Cash FlowNT$496.2M
Free Cash FlowNT$713.9M
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI52.5
SupportNT$75.80
ResistanceNT$84.00
MA 20NT$80.97
MA 50NT$80.89
MA 200NT$83.38
MACDBearish
VolumeIncreasing
Fear & Greed Index77.2

Valuation

Fair ValueNT$121.15
Target PriceNT$94.00
Upside/Downside14.63%
GradeUndervalued
TypeValue
Dividend Yield5.39%

Risk Assessment

Beta0.74
Volatility33.85%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.